Sponsored by:

Nuclear Medicine: Page 131

Cubresa to introduce new preclinical PET scanner
By AuntMinnie.com staff writers
Cubresa plans to unveil a new MR-compatible small-animal PET scanner at next month's Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
May 26, 2015
PETNet, Blue Earth ink prostate PET agent deal
By AuntMinnie.com staff writers
PETNet Solutions has inked an agreement with Blue Earth Diagnostics for the exclusive manufacturing and distribution of a radiopharmaceutical for PET/CT scans.
May 20, 2015
NRC issues impact statement for Shine facility
By AuntMinnie.com staff writers
The Nuclear Regulatory Commission (NRC) has released a draft environmental impact statement for Shine Medical Technologies' proposed medical isotope production facility in Janesville, WI.
May 19, 2015
SNMMI preps for annual meeting
By AuntMinnie.com staff writers
It's all systems go for the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2015 annual meeting in Baltimore.
May 19, 2015
Ipsen bids for OctreoPharm
By AuntMinnie.com staff writers
French biotechnology firm Ipsen has inked an agreement to purchase German radiopharmaceutical developer OctreoPharm Sciences for a total price of up to 50 million euros ($55.7 million U.S.).
May 19, 2015
Analysis finds variance in uptake of amyloid PET tracers
By Wayne Forrest
PET scans can detect varying levels of amyloid in the brain that change with age and the presence of a genotype linked to Alzheimer's disease, according to a meta-analysis in the May Journal of the American Medical Association. The findings may enable clinicians to better tailor which patients receive the scans.
May 18, 2015
IsoRay reports flat sales
By AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical posted a nominal increase in revenue for its third quarter, but revenue was basically flat for the nine-month period.
May 17, 2015
International Isotopes posts lower Q1 sales
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes experienced a slight decline in sales in its first quarter, although gross profit increased over the prior year's quarter.
May 17, 2015
New PET tracer homes in on metastatic prostate cancer
By Wayne Forrest
Researchers from Johns Hopkins University have developed a PET radiopharmaceutical for imaging metastatic prostate cancer that so far has shown superior image quality with less radiation exposure in most radiosensitive organs than its predecessor.
May 14, 2015
2015 05 14 15 42 35 609 Dcf Py L Pomper 200
Lymphoseek sales power Navidea's Q1 results
By AuntMinnie.com staff writers
Navidea Biopharmaceuticals released financial results for the first quarter of fiscal 2015 that were up sharply thanks to growing sales of its Lymphoseek agent.
May 11, 2015
Prescan review slashes inpatient use of PET/CT
By Wayne Forrest
A New Jersey hospital was able to slash by more than half the number of inpatient pulmonary PET/CT scans being performed by having its nuclear medicine department act as a gatekeeper for exam orders, according to a study presented at the recent American Roentgen Ray Society annual meeting.
May 11, 2015
2015 05 11 17 31 09 328 Alpert Justin 175
SPECT differentiates PTSD from TBI in military veterans
By Wayne Forrest
Add SPECT to the list of imaging modalities that can help physicians distinguish between post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI), potentially leading to more appropriate treatment for military veterans.
May 10, 2015
2015 05 06 16 13 04 846 Ptsd Tbi Spect Raji 450 20150506232016
Previous Page
Page 131 of 440
Next Page